R/C IPRATROP DUO:Uses, Benefits, Dosage, Price & dosage,precautions and more..

Jul 12, 2024

R/C IPRATROP DUO 

Ipratropium (40mcg)& Levo -Salbutamol Sulphate (100mcg)

R/C IPRATROP DUO is a combination medication consisting of Ipratropium Bromide (40mcg) and Levo-Salbutamol Sulphate (100mcg). This medication is primarily used for the treatment of respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma. By combining these two active ingredients, R/C IPRATROP DUO offers a potent and effective approach to managing respiratory issues, ensuring better airflow and improved breathing for patients.

Uses and Indications

R/C IPRATROP DUO is indicated for:

  • Chronic Obstructive Pulmonary Disease (COPD): This medication helps to open up the airways, making it easier for COPD patients to breathe.
  • Asthma: For patients experiencing asthma symptoms, R/C IPRATROP DUO can provide rapid relief by relaxing the muscles in the airways.
  • Bronchitis: It is also effective in treating bronchitis by reducing bronchospasm and improving breathing.

Mechanism of Action

Ipratropium Bromide

Ipratropium Bromide is an anticholinergic agent. It works by blocking the action of acetylcholine on muscarinic receptors in the airway smooth muscles. This action prevents the muscles from contracting, thereby dilating the airways and facilitating easier breathing.

Levo-Salbutamol Sulphate

Levo-Salbutamol Sulphate is a beta-2 adrenergic agonist. It stimulates beta-2 receptors in the bronchial muscles, leading to muscle relaxation and bronchodilation. This reduces airway resistance and increases airflow to the lungs.

Dosage and Administration

Inhalation Route

  • Adults and Children (above 12 years): The usual recommended dose is one inhalation (40mcg of Ipratropium and 100mcg of Levo-Salbutamol) four times a day. The dosage may be adjusted based on the severity of the condition and the patient's response to treatment.
  • Children (below 12 years): The dosage should be determined by a healthcare professional based on the child's age, weight, and severity of symptoms.

Nebulizer Solution

  • Adults and Children (above 12 years): One unit dose vial (containing 40mcg of Ipratropium and 100mcg of Levo-Salbutamol) diluted in saline for nebulization, three to four times a day.
  • Children (below 12 years): Dosage to be determined by a healthcare provider.

Side Effects

Most side effects are mild and temporary, but some can be more serious. Common side effects include:

  • Dry Mouth: Due to the anticholinergic effect of Ipratropium.
  • Tremors: A common side effect of beta-2 agonists like Levo-Salbutamol.
  • Headache: Can occur but usually subsides with continued use.
  • Cough: Sometimes, patients may experience a cough immediately after inhalation.
  • Palpitations: Rare but possible, especially in higher doses.

Precautions and Warnings

  • Allergies: Patients allergic to Ipratropium, Levo-Salbutamol, or any other component of the medication should avoid using R/C IPRATROP DUO.
  • Heart Conditions: Use with caution in patients with cardiovascular disorders as beta-2 agonists can cause palpitations and changes in heart rate.
  • Glaucoma: Ipratropium can increase intraocular pressure; therefore, caution is advised for patients with narrow-angle glaucoma.

Drug Interactions

R/C IPRATROP DUO may interact with other medications, potentially altering their effects. Important interactions include:

  • Other Bronchodilators: Concurrent use can enhance the bronchodilatory effect, which may be beneficial but requires medical supervision.
  • Beta-blockers: Can reduce the effectiveness of Levo-Salbutamol.
  • Diuretics: May increase the risk of hypokalemia when used with Levo-Salbutamol.

Benefits of R/C IPRATROP DUO

  • Combination Therapy: By combining two bronchodilators with different mechanisms of action, this medication offers superior efficacy compared to using either agent alone.
  • Rapid Relief: Provides quick relief from bronchospasm, making it ideal for acute symptom management.
  • Improved Quality of Life: Regular use can significantly improve breathing, allowing patients to perform daily activities with less difficulty.

Storage and Handling

  •  Storage : Keep out of reach of children.
  • Handling: Ensure the inhaler or nebulizer device is clean and functioning properly before use. Follow the instructions for use carefully to ensure proper delivery of the medication.

Conclusion

R/C IPRATROP DUO, containing Ipratropium (40mcg) and Levo-Salbutamol Sulphate (100mcg), is an effective treatment option for managing respiratory conditions such as COPD and asthma. Its dual-action mechanism provides rapid and sustained bronchodilation, making it a valuable medication for patients struggling with breathing difficulties. Always consult with a healthcare provider to determine the appropriate dosage and to monitor for potential side effects and interactions. With proper use, R/C IPRATROP DUO can significantly enhance the quality of life for those suffering from chronic respiratory conditions. Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology

For further information

Email: info@sterispharma.com /  contact@sterispharma.com

Call/WhatsApp:  7877551268, 7849827488

BUY NOW

SHARE WITH